Follistatin
Also known as: FST, FS344, FS315
Buy in shop
Follistatin from $368/kit
2 verified vendors, ≥99% purity, COAs included.
Key Facts: Follistatin
- Category
- Hormonal
- FDA Status
- Not FDA Approved
- Clinical Status
- Investigational - Gene therapy trials
- Administration
- Subcutaneous injection
- Typical Dose
- Limited community data available
- Frequency
- See research protocols
- Duration
- Variable protocols
Mechanism of Action
Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as an endogenous off-switch on muscle growth, signaling through activin type II receptors. Follistatin binds and sequesters myostatin (and related ligands like certain activins) so they cannot dock on their receptors, effectively releasing the brake and allowing muscle fibers to enlarge. By neutralizing several TGF-beta family members at once, follistatin can drive more muscle hypertrophy in animal models than narrower myostatin blockers. The hypothesis behind the therapy is straightforward: more free follistatin means less active myostatin means bigger, less fibrotic muscle.
Research Summary
The strongest human data comes from a Phase 1/2a gene therapy trial using AAV1.CMV.FS344 injected directly into the quadriceps of six men with Becker muscular dystrophy, published in Molecular Therapy in 2015. Several patients improved on the 6-minute walk test, by roughly 58 to 125 meters in one cohort, while one or two showed no benefit, and muscle biopsies showed reduced fibrosis, more normal fiber size, and hypertrophy with no serious adverse effects reported. The same gene-transfer approach was also studied in sporadic inclusion body myositis. This is genuinely promising but still early: tiny sample sizes, an open-label design without a placebo arm, local intramuscular delivery, and no large controlled trials yet confirm a durable functional benefit. It is also worth being blunt that the popular bodybuilding version, injecting follistatin peptide for muscle gains, has essentially no controlled human evidence behind it and is a different thing from the gene therapy studied in patients.
Dosing Information
Typical Dosingⓘ
Community experience
Limited community data available
See research dosing
See research protocols
Research Dosingⓘ
Scientific studies
Doses from research use
Doses from Studies
100-300 mcg daily
Limited standardization
Duration
Variable protocols
Administration
Subcutaneous injection
Timing & Administration
Best Time to Take
Morning
Once daily
Food Recommendation
With or without food
Why This Timing?
Follistatin inhibits myostatin. Consistent daily timing supports stable levels.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Muscle soreness
- ●Injection site reactions
- ●Flu-like symptoms
- ●Slight LDL cholesterol increase
- ●Potential FSH suppression
- ●Product quality concerns (black market)
References
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4426808/
- https://pubmed.ncbi.nlm.nih.gov/25322757/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2717722/
- https://clinicaltrials.gov/study/NCT01519349
Research This Peptide Further
Buy in shop
Follistatin from $368/kit
2 verified vendors, ≥99% purity, COAs included.
Frequently Asked Questions
What does Follistatin do?
Follistatin is a naturally occurring protein in your body whose claim to fame is shutting down myostatin, the brake that limits how much muscle you can build. Block myostatin and muscle grows, which is why follistatin has been chased hard as a therapy for muscle-wasting diseases and, less responsibly, as a physique-enhancement target. Most of the serious work uses gene therapy that tells muscle to produce follistatin, not injectable follistatin peptide, and nothing here is FDA approved.
How does Follistatin work?
Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as an endogenous off-switch on muscle growth, signaling through activin type II receptors. Follistatin binds and sequesters myostatin (and related ligands like certain activins) so they cannot dock on their receptors, effectively releasing the brake and allowing muscle fibers to enlarge. By neutralizing several TGF-beta family members at once, follistatin can drive more muscle hypertrophy in animal models than narrower myostatin blockers. The hypothesis behind the therapy is straightforward: more free follistatin means less active myostatin means bigger, less fibrotic muscle.
Is Follistatin FDA approved?
No, Follistatin is not currently FDA approved. Current status: Investigational - Gene therapy trials
What are the side effects of Follistatin?
Reported side effects include: Muscle soreness, Injection site reactions, Flu-like symptoms, Slight LDL cholesterol increase, Potential FSH suppression. Individual responses vary based on dosage, duration, and personal health factors.
What is the typical dose of Follistatin?
Community-reported common dose: Limited community data available (See research protocols). Range: See research dosing. Administration: Subcutaneous injection. Community-reported doses. Not medical advice. Consult healthcare provider.
Related Peptides
Peptides commonly compared with Follistatin or used in similar applications.
Kisspeptin
Clinical TrialsKisspeptin is the master switch that tells your brain to start reproduction. It is a family of peptides (the full length is kisspeptin-54, with shorter active fragments KP-14, KP-13, and KP-10) made from the KISS1 gene, and it acts as the upstream trigger for the entire reproductive hormone cascade. It is not an approved drug, but it has been tested in real human trials for fertility, hypothalamic amenorrhea, and male hypogonadism, with promising early results.
HormonalMOTS-c
PreclinicalMOTS-c is a 16-amino-acid peptide your own mitochondria make, encoded inside the 12S rRNA region of mitochondrial DNA and discovered in 2015. It is studied as a metabolic regulator and a so-called exercise mimetic, because its levels rise when you work out and it improves insulin sensitivity in animals. The catch: the impressive results are almost entirely in mice, with no completed published human efficacy trials.
HormonalOxytocin
FDAOxytocin is a 9-amino-acid hormone made in the hypothalamus, famous as the chemistry behind labor contractions, breastfeeding, and social bonding. As an injectable drug it is FDA-approved to induce labor and control postpartum bleeding, but the intranasal 'love hormone' versions sold for trust, anxiety, and autism are experimental and the human results are genuinely mixed. The hype runs well ahead of the evidence.
HormonalGonadorelin
FDAGonadorelin is a synthetic copy of natural GnRH (gonadotropin-releasing hormone), a 10-amino-acid peptide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) that tells the pituitary to release LH and FSH. It is FDA-approved for evaluating pituitary function and has historical use in inducing ovulation. In the peptide world it is mostly used off-label to keep the testes working during testosterone replacement, and the catch is that timing matters enormously: pulse it and you stimulate, give it continuously and you shut the system down.
HormonalLeuprolide
FDALeuprolide (brand name Lupron) is a synthetic GnRH agonist, a modified peptide about 20 times more potent than natural GnRH, and it is FDA-approved for advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. The clever part is counterintuitive: it works by overstimulating the GnRH system so hard that the pituitary shuts down sex hormone production. It is a real, long-established prescription drug, not a research peptide, and it carries meaningful side effects from the low-hormone state it creates.
HormonalDesmopressin
FDADesmopressin (dDAVP) is a synthetic tweak of the natural hormone vasopressin, redesigned to keep the water-retaining effect while dropping most of the blood-pressure effect. It is a long-established FDA-approved drug used for central diabetes insipidus, bedwetting and nocturia, and certain bleeding disorders like von Willebrand disease and mild hemophilia A. This is settled medicine, not an experimental peptide, and its main real-world danger is straightforward: it can drop your blood sodium dangerously low if you drink too much fluid on it.
HormonalWant updates on Follistatin research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.